TennCare - As introduced, requires a managed care organization or pharmacy benefits manager that is contracted with the bureau to reimburse a claim for a long-acting injectable drug intended for treatment and prevention of human immunodeficiency virus and administered in a pharmacy, physician's office, clinic, ambulatory surgical treatment center, or hospital. - Amends TCA Title 4; Title 56 and Title 71.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 7 Sponsors

No summary has been published for this bill. The full text is on the Bill text tab.

Chamber: House
Introduced: Feb 3, 2026
Last action: Mar 3, 2026 — Taken off notice for cal in s/c Tenncare Subcommittee of Insurance Committee
Session: 114
Momentum: 29 · Low

PASSAGE PROBABILITY

24.4% Unlikely

Why this number

Stage base In Committee — base rate 51%, measured from TN's completed sessions
Momentum -5 29/100 from the pace of recorded action
Time since last action -22 226 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.